Veroni, C.; Olla, S.; Brignone, M.S.; Siguri, C.; Formato, A.; Marra, M.; Manzoli, R.; Macario, M.C.; Ambrosini, E.; Moro, E.;
et al. The Antioxidant Drug Edaravone Binds to the Aryl Hydrocarbon Receptor (AHR) and Promotes the Downstream Signaling Pathway Activation. Biomolecules 2024, 14, 443.
https://doi.org/10.3390/biom14040443
AMA Style
Veroni C, Olla S, Brignone MS, Siguri C, Formato A, Marra M, Manzoli R, Macario MC, Ambrosini E, Moro E,
et al. The Antioxidant Drug Edaravone Binds to the Aryl Hydrocarbon Receptor (AHR) and Promotes the Downstream Signaling Pathway Activation. Biomolecules. 2024; 14(4):443.
https://doi.org/10.3390/biom14040443
Chicago/Turabian Style
Veroni, Caterina, Stefania Olla, Maria Stefania Brignone, Chiara Siguri, Alessia Formato, Manuela Marra, Rosa Manzoli, Maria Carla Macario, Elena Ambrosini, Enrico Moro,
and et al. 2024. "The Antioxidant Drug Edaravone Binds to the Aryl Hydrocarbon Receptor (AHR) and Promotes the Downstream Signaling Pathway Activation" Biomolecules 14, no. 4: 443.
https://doi.org/10.3390/biom14040443
APA Style
Veroni, C., Olla, S., Brignone, M. S., Siguri, C., Formato, A., Marra, M., Manzoli, R., Macario, M. C., Ambrosini, E., Moro, E., & Agresti, C.
(2024). The Antioxidant Drug Edaravone Binds to the Aryl Hydrocarbon Receptor (AHR) and Promotes the Downstream Signaling Pathway Activation. Biomolecules, 14(4), 443.
https://doi.org/10.3390/biom14040443